HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Body weight-based natalizumab treatment in adult patients with multiple sclerosis.

AuthorsM Tanaka, M Kinoshita, J F Foley, K Tanaka, J Kira, W M Carroll
JournalJournal of neurology (J Neurol) Vol. 262 Issue 3 Pg. 781-2 (Mar 2015) ISSN: 1432-1459 [Electronic] Germany
PMID25663410 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Immunologic Factors
  • Natalizumab
Topics
  • Aged
  • Body Weight
  • Female
  • Humans
  • Immunologic Factors (therapeutic use)
  • Male
  • Middle Aged
  • Multiple Sclerosis (drug therapy)
  • Natalizumab (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: